pig
effici
convert
feed
grain
valuabl
anim
protein
result
swine
industri
provid
energi
protein
human
be
obtain
anim
sourc
pond
industri
annual
provid
kg
highqual
protein
person
unit
state
increas
product
effici
innov
manag
practic
institut
biolog
use
reduc
diseaserel
loss
moreov
swine
product
chang
larg
number
small
farm
rel
small
number
larg
oper
intens
natur
product
unit
loss
due
contagi
diseas
magnifi
especi
manifest
respiratori
reproduct
enter
system
prevent
diseas
swine
routin
vaccin
common
pathogen
respons
signific
mortal
morbid
reduc
weight
gain
live
vaccin
use
exampl
viral
diseas
rotaviru
transmiss
gastroenter
viru
pseudorabi
viru
parvoviru
spite
avail
effect
vaccin
diseas
novel
pathogen
eg
porcin
respiratori
reproduct
syndrom
viru
continu
emerg
attenu
viru
eg
pseudorabi
viru
vaccin
becom
latent
although
econom
impact
swine
diseas
vari
signific
loss
due
infecti
agent
still
occur
current
inform
diseaserel
loss
avail
accord
report
committe
csr
anim
health
research
program
major
diseaserel
loss
attribut
respiratori
infect
million
reproduct
disord
million
enter
infect
million
annual
regard
three
distinct
swine
diseas
viral
origin
briefli
describ
next
aujeszki
diseas
caus
herpesviru
pseudorabi
viru
respons
signific
econom
loss
swine
industri
diseas
contagi
character
encephalomyel
inflamm
upper
respiratori
tract
mortal
reach
piglet
week
age
respiratori
form
diseas
common
grow
adult
pig
pregnant
sow
abort
mummif
fetus
stillbirth
occur
depend
stage
pregnanc
recov
subclin
infect
pig
continu
shed
viru
lead
persist
herd
infect
annual
cost
pseudorabi
swine
produc
million
miller
et
al
vaccin
provid
clinic
protect
diseas
prevent
shed
multipl
viru
thu
anim
remain
carrier
variabl
period
becom
sourc
infect
suscept
anim
therefor
import
vaccin
prevent
reduc
viru
shed
extent
transmiss
suscept
anim
reduc
attenu
viru
sever
genet
engin
delet
mutant
develop
evalu
abil
reduc
viru
shed
impact
vaccin
yet
fulli
known
sever
countri
attempt
erad
pseudorabi
viru
infect
swine
popul
without
use
vaccin
howev
certain
region
feral
swine
harbor
latent
viru
still
potenti
sourc
infect
domest
swine
erad
pseudorabi
viru
popul
practic
imposs
diarrheal
diseas
common
signific
problem
among
neonat
pig
econom
loss
unit
state
due
neonat
diarrhea
estim
excess
million
annual
similar
problem
encount
countri
australia
mullan
et
al
estim
loss
per
breed
sow
ensu
month
infect
transmiss
gastroenter
viru
tgev
accord
nation
anim
monitor
system
ofusda
tge
cost
pork
industri
locat
iowa
alon
million
annual
hill
tgev
caus
highli
contagi
enter
diseas
affect
pig
age
case
neonat
pig
tge
character
sever
diarrhea
vomit
mortal
approach
diseas
caus
coronaviru
shed
fece
nasal
secret
current
vaccin
consist
attenu
inactiv
tgev
inadequ
saif
jackwood
saif
wesley
recent
year
econom
import
emerg
pathogen
porcin
respiratori
reproduct
syndrom
prr
viru
respons
signific
loss
swine
industri
clinic
sign
diseas
rang
inappar
infect
sever
loss
pig
product
occur
type
swine
product
system
becker
schwartz
prr
viru
strain
variabl
virul
caus
reproduct
respiratori
tract
diseas
modifi
live
viru
vaccin
prr
avail
although
consider
amount
evid
suggest
vaccin
clearli
entir
solut
prr
problem
sever
form
prr
recent
emerg
iowa
despit
vaccin
halbur
bush
greatest
triumph
histori
diseas
prevent
erad
came
toward
end
eighteenth
centuri
edward
jenner
introduc
inocul
smallpox
jenner
work
led
develop
mani
human
anim
vaccin
rapid
advanc
scienc
immunolog
virolog
vaccinolog
vaccin
repres
import
tool
prevent
erad
diseas
regard
greatest
achiev
centuri
erad
smallpox
prevent
diseas
vaccin
shown
extrem
benefici
reduc
mortal
morbid
also
reduc
cost
anim
product
addit
provid
protect
vaccin
anim
vaccin
also
reduc
spread
infect
due
rel
low
cost
vaccin
popular
instrument
diseas
prevent
offer
import
form
invest
longrang
success
anim
industri
impact
vaccin
prevent
control
diseas
becom
increasingli
recogn
research
aspect
vaccin
increas
consider
recent
year
tradit
approach
vaccin
develop
includ
modifi
live
attenu
inactiv
vaccin
mani
instanc
attenu
attempt
serial
passag
virul
viru
vitro
cell
cultur
system
live
attenu
vaccin
develop
tri
establish
balanc
maximum
immunogen
minimum
virul
host
genet
makeup
vaccin
strain
known
mani
case
risk
revers
virul
field
condit
efficaci
vaccin
usual
determin
protect
immun
respons
host
immun
broken
overwhelm
challeng
vaccin
claim
perfect
recoveri
natur
infect
usual
lead
strong
longlast
protect
reinfect
pathogen
although
vaccin
complet
safe
normal
induc
strong
immun
natur
infect
efficaci
induc
appreci
degre
protect
immun
host
expos
reason
natur
challeng
attenu
modifi
live
vaccin
gener
prefer
sinc
provid
strong
longlast
immun
easili
produc
inactiv
vaccin
howev
mention
earlier
often
pose
threat
revers
virul
transmiss
speci
often
requir
maintain
correct
passag
level
moreov
vaccin
produc
differ
biolog
manufactur
may
vari
potenti
revers
virul
furthermor
probabl
vivo
recombin
either
differ
vaccin
strain
andor
field
strain
exampl
pseudorabi
viru
result
gener
strain
greater
virul
origin
vaccin
strain
concern
unwarr
use
inactiv
subunit
vaccin
howev
frequent
administr
requir
therefor
applic
kill
vaccin
becom
expens
use
live
vaccin
although
design
vaccin
main
emphasi
protect
host
diseas
also
import
consid
durat
immun
lack
advers
effect
eas
administr
low
cost
increas
number
vaccin
common
emerg
pathogen
made
individu
administr
impract
regard
biolog
compani
realiz
long
time
advantag
combin
vaccin
protect
sever
diseas
multiantigen
vaccin
requir
rel
lower
number
inject
cost
packag
storag
deliveri
equip
labor
reduc
problem
associ
use
current
vaccin
overcom
develop
new
gener
live
vaccin
protect
antigen
pathogen
present
immun
system
host
chanc
revers
virul
elimin
vaccin
benefici
properti
live
kill
vaccin
retain
avail
molecular
method
knowledg
enabl
us
overcom
limit
tradit
approach
vaccin
develop
use
modern
genet
engin
techniqu
possibl
isol
identifi
sequenc
import
gene
pathogen
organ
place
new
vector
faith
express
bacteri
viral
vector
use
express
foreign
gene
bacteria
easi
manipul
provid
high
level
express
bacteria
glycosyl
proteolyt
process
subunit
assembl
eukaryot
protein
may
occur
properli
consequ
use
vector
may
result
product
authent
protein
therefor
genom
small
larg
virus
exampl
baculovirus
adenovirus
herpesvirus
poxvirus
manipul
express
foreign
protein
genom
larges
virus
eg
poxvirus
herpesvirus
difficult
alter
capac
express
signific
amount
foreign
genet
materi
ie
sever
foreign
gene
consid
herpesvirus
vaccin
vector
howev
import
consid
potenti
delay
persist
oncogenesi
hand
smallsiz
virus
eg
adenovirus
limit
genom
accommod
small
amount
foreign
genet
materi
without
viru
becom
defect
replic
although
poxvirus
concern
mani
year
virtu
impact
human
anim
health
recent
increas
interest
virus
stem
use
viral
vector
moss
flexner
extens
experi
obtain
use
vaccinia
viru
live
vaccin
well
wide
host
rang
larg
size
genom
capabl
accommod
substanti
amount
foreign
dna
inabl
induc
oncogen
transform
import
featur
favor
potenti
use
vector
immun
import
pathogen
addit
genet
alter
vaccinia
virus
maintain
infect
insert
foreign
gene
induc
humor
cellular
immun
vaccinia
vector
vaccin
rel
inexpens
produc
easi
administ
sinc
first
demonstr
abil
vaccinia
viru
express
insert
herp
simplex
viru
thymidin
kinas
tk
gene
panicali
paoletti
larg
varieti
foreign
gene
express
recombin
vaccinia
virus
gene
encod
antigen
respons
elicit
immun
respons
result
recombin
virus
shown
elicit
protect
immun
anim
respect
pathogen
thu
foreign
gene
express
vaccinia
viru
regul
protein
produc
nativ
state
genom
vaccinia
viru
abil
accept
bp
insert
foreign
dna
foreign
gene
could
conceiv
express
singl
live
recombin
viru
flexner
moss
thu
demonstr
potenti
success
vaccinia
viru
gene
express
vector
kept
popular
unchalleng
mani
year
howev
wide
host
rang
reluct
accept
vacciniavector
vaccin
due
postvaccin
complic
human
gurvich
observ
use
vaccinia
erad
smallpox
consequ
technolog
appli
hostspecif
avianpox
virus
eg
fowlpox
canarypox
virus
use
vector
greatli
restrict
replic
abil
provid
safeti
advantag
host
well
come
contact
spite
limit
basic
inform
genom
virus
remark
progress
made
develop
avianpox
viru
vector
vaccin
key
event
led
earli
success
continu
use
live
fowlpox
viru
vaccin
poultri
industri
year
prevent
fowlpox
chicken
turkey
effect
substitut
heterolog
vaccinia
viru
promot
lieu
homolog
avianpox
viru
promot
tripathi
wittek
schnitzlein
tripathi
develop
recombin
fowlpox
viru
vector
abil
primari
well
perman
cell
line
avian
origin
support
growth
fowlpox
viru
avail
sever
gene
encod
specif
protein
poultri
pathogen
consequ
sever
recombin
fowlpox
virus
express
specif
protein
varieti
avian
pathogen
creat
immun
suscept
bird
recombin
result
develop
specif
antibodi
enabl
protect
subsequ
challeng
respect
virul
pathogen
tripathi
develop
result
licens
recombin
fowlpox
viru
vaccin
express
hemagglutinin
newcastl
diseas
viru
addit
shown
avianpox
virus
eg
fowlpox
canarypox
virus
express
foreign
antigen
induc
immun
respons
mammalian
host
taylor
et
al
taylor
et
al
without
caus
product
infect
consid
swinepox
viru
express
vector
gene
swine
pathogen
necessari
mention
sever
virus
engin
express
gene
encod
protect
antigen
swine
pathogen
exampl
tuboli
et
al
show
baculovirusexpress
spike
protein
transmiss
gastroenter
viru
capabl
induc
tgevspecif
antibodi
igg
class
pig
recombin
pseudorabi
viru
express
envelop
glycoprotein
hog
cholera
viru
provid
protect
pseudorabi
hog
cholera
classic
swine
fever
virus
van
zijl
et
al
highli
attenu
strain
ofvaccinia
viru
develop
tartaglia
et
al
use
vector
express
pseudorabi
viru
protein
evalu
protect
brockmeier
et
al
brockmeier
et
al
mengel
et
al
success
vaccinia
avianpox
virus
express
vector
provid
impetu
consid
use
swinepox
viru
express
antigen
swine
pathogen
like
vaccinia
viru
swinepox
viru
brickshap
genom
consist
doublestrand
dna
approxim
kb
massung
moyer
distinct
member
genu
suipoxviru
worldwid
distribut
vaccinia
fowlpox
viru
modif
swinepox
viru
express
vector
practic
due
certain
biolog
attribut
includ
host
specif
mild
pathogen
thermo
stabil
low
transmiss
tripathi
et
al
hous
hous
tripathi
restrict
replic
abil
swinepox
viru
attenu
natur
provid
safeti
advantag
recipi
also
nonvaccin
contact
case
modifi
viral
vector
main
safeti
concern
whether
vector
virul
capabl
produc
clinic
diseas
host
develop
product
applic
convent
vaccin
base
sever
factor
safeti
efficaci
cost
well
serious
diseas
swinepox
viru
infect
mild
occur
rare
need
develop
vaccin
never
realiz
isol
case
swinepox
report
recent
year
olffumi
et
al
borst
et
al
genet
antigen
differ
virus
known
unlik
vaccinia
viru
limit
basic
appli
research
done
viru
recent
year
howev
due
recent
interest
poxvirus
vaccin
vector
studi
molecular
biolog
viru
conduct
massung
moyer
b
larg
size
genom
like
vaccinia
viru
swinepox
viru
accommod
signific
amount
foreign
genet
materi
possibl
develop
polyval
vaccin
cell
line
porcin
origin
support
growth
swinepox
viru
avail
mani
year
poxviru
vector
vaccin
antigen
express
swinepox
viru
properli
process
glycosyl
final
recombin
swinepox
viru
vector
vaccin
would
safer
convent
live
vaccin
sinc
contain
minor
portion
genom
foreign
pathogen
far
nonessenti
locu
identifi
swinepox
viru
genom
tk
gene
sinc
studi
poxvirus
includ
fowlpox
viru
tripathi
beard
et
al
shown
follow
insert
inactiv
tk
gene
recombin
virus
becom
less
pathogen
parent
viru
result
recombin
swinepox
viru
becom
less
virul
parent
viru
thu
swine
industri
would
benefit
new
gener
recombin
swinepox
viru
vector
vaccin
desir
featur
viru
basic
recombin
dna
techniqu
use
construct
vaccinia
viru
fowlpox
viru
recombin
modifi
extend
swinepox
viru
briefli
describ
first
step
product
recombin
virus
creat
plasmid
direct
insert
foreign
transcript
unit
viru
genom
insert
occur
homolog
recombin
thu
requir
foreign
dna
flank
contigu
viru
genom
region
case
vaccinia
fowlpox
viru
recombin
commonli
use
insert
site
foreign
gene
tk
gene
virus
regard
tk
gene
swinepox
viru
identifi
sequenc
feller
et
al
gene
tk
nonessenti
viru
replic
develop
swinepox
viru
recombin
vector
capabl
induc
immun
variou
swine
pathogen
requir
insert
foreign
gene
express
transcript
machineri
viru
recogn
hostcel
promot
foreign
gene
much
link
poxviru
promot
uniqu
conserv
natur
poxviru
transcript
regulatori
element
two
defin
vaccinia
viru
promot
pll
predominantli
use
creation
recombin
vaccinia
avianpox
virus
distantli
relat
fowlpox
viru
tripathi
wittek
schnitzlein
tripathi
promot
also
recogn
swinepox
viru
gener
vaccinia
viru
late
pll
promot
use
regul
transcript
marker
gene
wherea
express
gene
encod
protect
antigen
control
earlyl
promot
transcript
unit
posit
immedi
adjac
flank
viru
dna
sequenc
ensur
insert
viru
genom
plasmid
gener
transfect
pig
kidney
cell
previous
infect
swinepox
viru
recombin
gener
homolog
recombin
replic
swinepox
viru
genom
transfect
plasmid
shown
schemat
fig
progeni
infect
retain
parent
genom
procedur
screeningselect
recombin
progeni
requir
one
method
identif
util
escherichia
coli
lacz
gene
marker
case
chromogen
substrat
indolyldgalactosidas
xgal
convert
blue
compound
action
express
enzym
galactosidas
use
identifi
viru
plaqu
produc
recombin
viru
progeni
background
colorless
plaqu
gener
nonrecombin
virus
altern
recombin
carri
e
coli
xanthineguanin
phosphoribosyl
transferas
gene
gpt
marker
select
due
resist
mycophenol
acid
boyl
coupar
addit
recombin
virus
identifi
plaqu
hybrid
use
dna
probe
specif
insert
foreign
gene
thymidin
kinasedefici
tk
cell
use
effect
select
recombin
virus
foreign
gene
introduc
within
tk
gene
sinc
tkcell
line
swine
origin
allow
select
growth
recombin
tkswinepox
viru
avail
inclus
marker
gene
becom
import
facilit
selectionscreen
recombin
viru
regardless
identif
procedur
viru
stock
prepar
plaqu
wildtyp
viru
detect
two
consecut
round
infect
product
authent
antigen
recombin
swinepox
viru
verifi
use
specif
antibodi
respect
protein
immunoprecipit
assay
detect
immunofluoresc
surfac
cell
infect
recombin
virus
fig
fig
cell
infect
recombin
swinepox
viru
express
giii
glycoprotein
pseudorabi
viru
specif
immunofluoresc
observ
follow
reaction
antibodi
giii
glycoprotein
pseudorabi
viru
use
abovement
protocol
recombin
swinepox
virus
express
giii
glycoprotein
pseudorabi
viru
gener
tripathi
et
al
envelop
glycoprotein
chosen
due
import
induct
protect
immun
sever
pseudorabi
viru
glycoprotein
identifi
giii
shown
induc
antibodi
neutral
viru
marchioli
et
al
zuckermann
et
al
also
provid
protect
subsequ
lethal
challeng
marchioli
et
al
gene
encod
glycoprotein
separ
insert
swinepox
viru
genom
evalu
protect
abil
recombin
swinepox
virus
express
pseudorabi
viru
gene
suscept
pig
vaccin
either
two
recombin
mixtur
anim
vaccin
recombin
virus
protect
challeng
virul
pseudorbi
viru
contrast
either
mortal
occur
sever
clinic
diseas
develop
swine
mock
vaccin
inocul
unalt
swinepox
viru
tripathi
et
al
anim
inject
either
unalt
swinepox
viru
recombin
swinepox
viru
develop
local
lesion
site
inocul
regress
within
day
secondari
lesion
observ
anim
moreov
primari
lesion
result
recombin
swinepox
viru
infect
regress
faster
produc
parent
unmodifi
swinepox
viru
phenomenon
observ
poxvirus
tk
gene
insert
inactiv
evid
protect
recombin
swinepox
viru
express
glycoprotein
pseudorabi
viru
report
van
der
leek
et
al
studi
indic
swinepox
viru
vector
recombin
vaccin
capabl
express
foreign
gene
level
induc
protect
immun
host
specif
recombin
favor
use
ideal
immun
agent
swine
vaccin
diseas
carri
limit
econom
loss
caus
mortal
morbid
growth
retard
infect
anim
ultim
aim
howev
possibl
erad
diseas
regular
use
attenu
inactiv
vaccin
spite
regular
use
convent
vaccin
signific
loss
still
occur
therefor
new
improv
vaccin
need
mani
current
emerg
infecti
swine
diseas
contribut
unnecessari
mortal
morbid
signific
econom
loss
new
approach
vaccin
develop
express
gene
foreign
pathogen
use
live
attenu
viral
vaccin
vector
regard
larg
size
virus
pox
herpesvirus
promis
howev
mention
earlier
herpesvirus
potenti
reactiv
latenc
result
recurr
infect
possibl
shed
viru
possibl
certain
instanc
vivo
recombin
differ
vaccin
strain
may
result
gener
recombin
virul
greater
involv
vaccin
strain
vaccinia
viru
vector
vaccin
hand
prove
highli
success
immun
agent
regular
applic
live
recombin
vaccinia
virus
controversi
minor
complic
associ
vaccin
program
smallpox
therefor
develop
live
vaccin
selfrestrict
transmit
vaccin
anim
contact
anim
releas
environ
would
ideal
limit
experiment
studi
tkinactiv
swinepox
viru
indic
live
swinepox
viru
monoval
polyval
vaccin
vector
creat
lack
adequ
local
immun
parenter
administ
vaccin
pathogen
whose
portal
entri
respiratori
gastrointestin
tract
realiz
long
time
inde
vaccinia
vector
vaccin
administ
parenter
stimul
protect
level
serum
igg
antibodi
cellular
immun
induc
mucos
immun
associ
iga
antibodi
oral
immun
recombin
vaccinia
viru
contain
rabi
glycoprotein
gene
provid
protect
rabi
rupprecht
et
al
field
trial
conduct
oral
bait
vaccin
wild
anim
control
rabi
case
immun
probabl
occur
due
viral
replic
tonsil
safeti
efficaci
oral
vaccin
raccoon
feed
raccoonpox
viru
contain
rabi
viru
glycoprotein
spongebait
describ
esposito
et
al
enter
immun
mice
recombin
vaccinia
viru
contain
influenza
viru
hemagglutinin
gene
induc
mucos
iga
antibodi
serum
igg
antibodi
cellmedi
immun
meitin
et
al
similarli
mice
immun
intragastr
recombin
vaccinia
viru
contain
hemagglutinin
nucleoprotein
gene
influenza
viru
protect
influenza
bender
et
al
natur
case
swinepox
neonat
piglet
lesion
mouth
respiratori
tract
observ
indic
viru
replic
site
skin
addit
antibodi
sera
antibodi
iga
class
intestin
content
swine
infect
oral
swinepox
viru
observ
provid
evid
viru
multipl
oral
administr
tuboli
et
al
studi
suggest
swinepox
viru
potenti
vector
express
antigen
enter
respiratori
viral
agent
swine
use
oral
vaccin
enter
pathogen
would
conveni
mass
administr
drink
water
less
expens
convent
vaccin
addit
swinepox
viru
could
use
construct
multival
recombin
vaccin
abil
accommod
larg
amount
foreign
genet
materi
altern
combin
recombin
vaccin
express
differ
antigen
could
use
protect
multipl
pathogen
whether
oral
intranas
administr
recombin
swinepox
viru
vaccin
express
antigen
entericrespiratori
pathogen
would
induc
desir
protect
immun
respons
need
determin
effect
recombin
vaccin
ever
develop
swine
industri
would
benefit
tremend
like
avianpox
virus
swinepox
viru
never
isol
host
pig
interestingli
hostrestrict
recombin
avianpox
virus
shown
express
foreign
antigen
mammalian
host
without
produc
product
infect
similar
manner
recombin
swinepox
virus
contain
foreign
antigen
abl
express
optim
host
swine
without
product
infect
viru
could
becom
potenti
candid
vector
vaccin
wide
rang
speci
includ
man
sever
small
larg
virus
eg
adenoviru
poxviru
herpesvirus
investig
vaccin
vector
viral
system
advantag
disadvantag
one
major
advantag
viral
vector
vaccin
abil
elicit
protect
cellmedi
immun
well
humor
respons
antigen
deliv
vector
one
major
problem
use
recombin
virus
vaccin
pathogen
potenti
parent
viru
therefor
import
along
optim
express
foreign
gene
abil
provid
protect
pathogen
vector
viru
must
reduc
genet
manipul
without
affect
multipl
requir
develop
viral
vector
exampl
swinepox
viru
cell
cultur
system
support
growth
viru
suitabl
nonessenti
region
viru
genom
insert
foreign
dna
viru
replic
affect
foreign
gene
encod
immunogen
protein
swine
pathogen
strong
transcript
regulatori
element
promot
necessari
optim
express
foreign
gene
procedur
deliv
foreign
gene
nonessenti
locu
conveni
method
distinguish
recombin
virus
parent
wildtyp
viru
use
methodolog
recombin
swinepox
viru
vaccin
express
pseudorabi
viru
antigen
develop
shown
provid
protect
challeng
studi
evid
local
infect
oral
tract
swinepox
viru
indic
potenti
recombin
vector
provid
immun
variou
swine
pathogen
includ
infect
respiratori
gastrointestin
tract
author
would
like
thank
william
schnitzlein
help
suggest
fig
